Iferanserin Explained

Iferanserin (INN; VEN-309) is a drug which acts as a selective 5-HT2A receptor antagonist.[1] It is under development as an intra-rectal formulation for the treatment of hemorrhoid disease, and as of February 2012, is in phase IIb clinical trials.

Notes and References

  1. Herold A, Dietrich J, Aitchison R . Intra-anal Iferanserin 10 mg BID for hemorrhoid disease: a prospective, randomized, double-blind, placebo-controlled trial . Clinical Therapeutics . 34 . 2 . 329–40 . February 2012 . 22244049 . 10.1016/j.clinthera.2011.12.012 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Iferanserin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.